S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review

被引:12
|
作者
Nejat, Reza [1 ]
Torshizi, Maziar Fayaz [2 ]
Najafi, David J. [3 ]
机构
[1] Laleh Hosp, Dept Anesthesiol & Crit Care Med, Tehran 1467684595, Iran
[2] Imperial Coll London, Dept Chem Engn, London SW7 2AZ, England
[3] Alliance Retina Consultants, La Mesa, CA 91942 USA
关键词
ACE2; Ang II; angiotensin(1-7); AT1R; cathepsin; COVID-19; endocytosis; ERK1/2; furin; IL-1; beta; IL-6; MAPK; MasR; NF-kappa B; PLC; PKC; RAS; RBD; SARS-CoV-2; S protein; TMPRSS2; TNF-alpha; ANGIOTENSIN-CONVERTING ENZYME-2; II TYPE-1 RECEPTOR; SPIKE PROTEIN; SARS-COV; DOWN-REGULATION; DISEASE SEVERITY; SERINE-PROTEASE; ADAM17; ACTIVATION; CALCIUM;
D O I
10.3390/vaccines11020204
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since the spread of the deadly virus SARS-CoV-2 in late 2019, researchers have restlessly sought to unravel how the virus enters the host cells. Some proteins on each side of the interaction between the virus and the host cells are involved as the major contributors to this process: (1) the nano-machine spike protein on behalf of the virus, (2) angiotensin converting enzyme II, the mono-carboxypeptidase and the key component of renin angiotensin system on behalf of the host cell, (3) some host proteases and proteins exploited by SARS-CoV-2. In this review, the complex process of SARS-CoV-2 entrance into the host cells with the contribution of the involved host proteins as well as the sequential conformational changes in the spike protein tending to increase the probability of complexification of the latter with angiotensin converting enzyme II, the receptor of the virus on the host cells, are discussed. Moreover, the release of the catalytic ectodomain of angiotensin converting enzyme II as its soluble form in the extracellular space and its positive or negative impact on the infectivity of the virus are considered.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Filippo Scialo
    Aurora Daniele
    Felice Amato
    Lucio Pastore
    Maria Gabriella Matera
    Mario Cazzola
    Giuseppe Castaldo
    Andrea Bianco
    Lung, 2020, 198 : 867 - 877
  • [2] SARS-CoV-2 cell entry beyond the ACE2 receptor
    Shamila D. Alipoor
    Mehdi Mirsaeidi
    Molecular Biology Reports, 2022, 49 : 10715 - 10727
  • [3] SARS-CoV-2 cell entry beyond the ACE2 receptor
    Alipoor, Shamila D.
    Mirsaeidi, Mehdi
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (11) : 10715 - 10727
  • [4] ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Scialo, Filippo
    Daniele, Aurora
    Amato, Felice
    Pastore, Lucio
    Matera, Maria Gabriella
    Cazzola, Mario
    Castaldo, Giuseppe
    Bianco, Andrea
    LUNG, 2020, 198 (06) : 867 - 877
  • [5] Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
    Batlle, Daniel
    Monteil, Vanessa
    Garreta, Elena
    Hassler, Luise
    Wysocki, Jan
    Chandar, Vasuretha
    Schwartz, Robert E.
    Mirazimi, Ali
    Montserrat, Nuria
    Bader, Michael
    Penninger, Josef M.
    CELL, 2022, 185 (11) : 1837 - 1839
  • [6] Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
    Yeung, Man Lung
    Teng, Jade Lee Lee
    Yuen, Kwok-Yung
    CELL, 2022, 185 (11) : 1840 - 1841
  • [7] Soluble ACE2 in SARS-CoV-2 infection
    Yeung, M. L.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (5) : 297 - 297
  • [8] Soluble ACE2 in SARS-CoV-2 infection
    Susan Allison
    Nature Reviews Nephrology, 2021, 17 : 297 - 297
  • [9] Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
    Luan, Junwen
    Lu, Yue
    Jin, Xiaolu
    Zhang, Leiliang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (01) : 165 - 169
  • [10] Sars-CoV-2 and black population: ACE2 as shield or blade?
    Vinciguerra, Mattia
    Greco, Ernesto
    INFECTION GENETICS AND EVOLUTION, 2020, 84